The objective of this study was to find a clinically appropriate dose of PAC-14028 cream by comparatively evaluating the efficacy and safety of PAC-14028 cream of Amorepacific Corporation in patients with dermal pruritus.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
74
Kyu-Han Kim
Seoul, South Korea
Change in Visual Analog Scale (VAS)
Patient reported outcome of pruritis measurement on a change in visual analog scale
Time frame: Baseline through Study Day 28
Treatment success rate
Time frame: Baseline through Study Day 28
Change in specified symptom sum score (SRRC) Index
Time frame: Baseline through Study Day 28
Change in transepidermal water loss
Time frame: Baseline through Study Day 28
Change in skin hydration
Time frame: Baseline through Study Day 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.